Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
2(25%)
Results Posted
75%(3 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_2
1
13%
Ph not_applicable
4
50%
Ph early_phase_1
1
13%
Ph phase_1
2
25%

Phase Distribution

3

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
1(12.5%)
N/ANon-phased studies
4(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(4)
Terminated(2)

Detailed Status

Completed4
Active, not recruiting1
Terminated1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (12.5%)
Phase 12 (25.0%)
Phase 21 (12.5%)
N/A4 (50.0%)

Trials by Status

active_not_recruiting113%
completed450%
terminated113%
recruiting113%
withdrawn113%

Recent Activity

2 active trials
Showing 5 of 8
completedphase_2

Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer

NCT01507428
recruitingnot_applicable

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

NCT06325046
active_not_recruitingnot_applicable

Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer

NCT05830838
completednot_applicable

Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery

NCT02527304
completedearly_phase_1

MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer

NCT02683200
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT01507428Phase 2

Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer

Completed
NCT06325046Not Applicable

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

Recruiting
NCT05830838Not Applicable

Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer

Active Not Recruiting
NCT02527304Not Applicable

Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery

Completed
NCT02683200Early Phase 1

MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer

Completed
NCT01283178Phase 1

Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC

Terminated
NCT01843673Not Applicable

Image-Guided Adaptive Radiotherapy for in Detecting Tumors During Treatment in Patients With Head and Neck Cancer

Completed
NCT02059967Phase 1

Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC

Withdrawn

All 8 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
8